Kennes B, De Maubeuge J, Delespesse G
Clin Allergy. 1977 Jan;7(1):35-9. doi: 10.1111/j.1365-2222.1977.tb01422.x.
Twenty-four patients with chronic utricaria resistant to conventional therapy were treated orally with terbutaline, a specific beta2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1-25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria.
24例对传统疗法耐药的慢性荨麻疹患者口服特布他林（一种特异性β2激动剂）进行治疗。该疗法比抗组胺药更有效。每日3次，每次1 - 25毫克的剂量，副作用很少。疗效与IgE水平无关；在特发性病例中似乎比在胆碱能性或压力性荨麻疹中更显著。
